Detailed information for compound 583295

Basic information

Technical information
  • TDR Targets ID: 583295
  • Name: acetic acid; N4-(6-chloro-2-methoxy-acridin-9 -yl)-N1,N1-diethyl-pentane-1,4-diamine
  • MW: 460.009 | Formula: C25H34ClN3O3
  • H donors: 2 H acceptors: 3 LogP: 3.54 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(=O)O.CCN(CCCC(Nc1c2cc(OC)ccc2nc2c1ccc(c2)Cl)C)CC
  • InChi: 1S/C23H30ClN3O.C2H4O2/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23;1-2(3)4/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26);1H3,(H,3,4)
  • InChiKey: QMFWSMZJJLEFLM-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • acetic acid; N4-(6-chloro-2-methoxy-9-acridinyl)-N1,N1-diethylpentane-1,4-diamine
  • N4-(6-chloro-2-methoxy-acridin-9-yl)-N1,N1-diethyl-pentane-1,4-diamine; ethanoic acid
  • acetic acid; 4-[(6-chloro-2-methoxy-acridin-9-yl)amino]pentyl-diethyl-amine
  • acetic acid; 4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N,1-N-diethylpentane-1,4-diamine
  • Quinacrine
  • acetic acid; N'-(6-chloro-2-methoxyacridin-9-yl)-N,N-diethylpentane-1,4-diamine
  • acetic acid; N'-(6-chloro-2-methoxy-acridin-9-yl)-N,N-diethyl-pentane-1,4-diamine
  • acetic acid; N'-(6-chloro-2-methoxy-9-acridinyl)-N,N-diethylpentane-1,4-diamine
  • N'-(6-chloro-2-methoxy-acridin-9-yl)-N,N-diethyl-pentane-1,4-diamine; ethanoic acid
  • 78901-94-7
  • 1,4-Pentanediamine, N4-(6-chloro-2-methoxy-9-acridinyl)-N1,N1-diethyl-, monoacetate
  • N4-(6-Chloro-2-methoxy-9-acridinyl)-N1,N1-diethyl-1,4-pentanediamine monoacetate
  • Quinacrine acetate

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Leishmania major trypanothione reductase Curated by TDR Targets References
Leishmania major DNA topoisomerase ii Curated by TDR Targets References
Plasmodium falciparum lysophospholipase, putative Curated by TDR Targets References
Plasmodium falciparum esterase, putative Curated by TDR Targets References
Plasmodium falciparum lysophospholipase, putative Curated by TDR Targets References
Trypanosoma cruzi trypanothione reductase, putative Curated by TDR Targets No references
Leishmania major mitochondrial DNA topoisomerase II Curated by TDR Targets References
Trypanosoma cruzi trypanothione reductase, putative Curated by TDR Targets No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Plasmodium falciparum DNA gyrase subunit B Get druggable targets OG5_128755 All targets in OG5_128755
Schistosoma mansoni DNA topoisomerase II Get druggable targets OG5_127113 All targets in OG5_127113
Leishmania braziliensis mitochondrial DNA topoisomerase II Get druggable targets OG5_128755 All targets in OG5_128755
Candida albicans DNA topoisomerase II similar to S. cerevisiae TOP2 (YNL088W) Get druggable targets OG5_127113 All targets in OG5_127113
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase Get druggable targets OG5_127037 All targets in OG5_127037
Leishmania major monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Cryptosporidium hominis thioredoxin reductase Get druggable targets OG5_126785 All targets in OG5_126785
Leishmania donovani mitochondrial DNA topoisomerase II Get druggable targets OG5_128755 All targets in OG5_128755
Brugia malayi glutathione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Treponema pallidum DNA gyrase, subunit B (gyrB) Get druggable targets OG5_128755 All targets in OG5_128755
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase Get druggable targets OG5_127037 All targets in OG5_127037
Trypanosoma congolense trypanothione reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase Get druggable targets OG5_127037 All targets in OG5_127037
Giardia lamblia DNA topoisomerase II Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium falciparum lysophospholipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Plasmodium falciparum esterase, putative Get druggable targets OG5_144587 All targets in OG5_144587
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr Get druggable targets OG5_126785 All targets in OG5_126785
Trichomonas vaginalis conserved hypothetical protein Get druggable targets OG5_144587 All targets in OG5_144587
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_127113 All targets in OG5_127113
Chlamydia trachomatis DNA gyrase subunit B Get druggable targets OG5_127113 All targets in OG5_127113
Leishmania infantum trypanothione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Babesia bovis thiodoxin reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase Get druggable targets OG5_127037 All targets in OG5_127037
Neospora caninum Glutathione reductase, related Get druggable targets OG5_126785 All targets in OG5_126785
Neospora caninum MGC84926 protein, related Get druggable targets OG5_126785 All targets in OG5_126785
Trypanosoma cruzi trypanothione reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium yoelii DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium knowlesi DNA gyrase subunit B, putative Get druggable targets OG5_128755 All targets in OG5_128755
Candida albicans similar to YJU3 Get druggable targets OG5_127037 All targets in OG5_127037
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein Get druggable targets OG5_127037 All targets in OG5_127037
Onchocerca volvulus DNA topoisomerase 2 homolog Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium yoelii glutathione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein Get druggable targets OG5_144587 All targets in OG5_144587
Echinococcus multilocularis DNA topoisomerase 2 alpha Get druggable targets OG5_127113 All targets in OG5_127113
Loa Loa (eye worm) glutathione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_127113 All targets in OG5_127113
Trypanosoma brucei gambiense monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Plasmodium falciparum glutathione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Onchocerca volvulus Putative DNA topoisomerase 2, mitochondrial Get druggable targets OG5_127113 All targets in OG5_127113
Brugia malayi Thioredoxin reductase Get druggable targets OG5_126785 All targets in OG5_126785
Trypanosoma congolense DNA topoisomerase II, putative Get druggable targets OG5_128755 All targets in OG5_128755
Candida albicans similar to YJU3 Get druggable targets OG5_127037 All targets in OG5_127037
Theileria parva thioredoxin reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
Plasmodium knowlesi DNA topoisomerase 2, putative Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium vivax DNA gyrase subunit B, putative Get druggable targets OG5_128755 All targets in OG5_128755
Leishmania braziliensis monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Trypanosoma congolense monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Cryptosporidium parvum DNA topoisomerase II Get druggable targets OG5_127113 All targets in OG5_127113
Leishmania infantum mitochondrial DNA topoisomerase II Get druggable targets OG5_128755 All targets in OG5_128755
Wolbachia endosymbiont of Brugia malayi DNA gyrase, topoisomerase II, B subunit, GyrB Get druggable targets OG5_128755 All targets in OG5_128755
Trichomonas vaginalis conserved hypothetical protein Get druggable targets OG5_127037 All targets in OG5_127037
Leishmania braziliensis trypanothione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Schistosoma japonicum expressed protein Get druggable targets OG5_127113 All targets in OG5_127113
Toxoplasma gondii thioredoxin reductase Get druggable targets OG5_126785 All targets in OG5_126785
Theileria parva hypothetical protein Get druggable targets OG5_144587 All targets in OG5_144587
Trypanosoma brucei gambiense DNA topoisomerase II, putative Get druggable targets OG5_128755 All targets in OG5_128755
Trypanosoma brucei monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Toxoplasma gondii DNA topoisomerase 2, putative Get druggable targets OG5_127113 All targets in OG5_127113
Leishmania mexicana mitochondrial DNA topoisomerase II Get druggable targets OG5_128755 All targets in OG5_128755
Schistosoma japonicum ko:K00384 thioredoxin reductase (NADPH) [EC1.8.1.9], putative Get druggable targets OG5_126785 All targets in OG5_126785
Leishmania donovani trypanothione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Cryptosporidium parvum thioredoxin reductase 1 Get druggable targets OG5_126785 All targets in OG5_126785
Trichomonas vaginalis DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Theileria parva DNA gyrase subunit B, putative Get druggable targets OG5_128755 All targets in OG5_128755
Babesia bovis DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Entamoeba histolytica DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium vivax unspecified product Get druggable targets OG5_144587 All targets in OG5_144587
Plasmodium falciparum esterase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Neospora caninum hypothetical protein Get druggable targets OG5_144587 All targets in OG5_144587
Leishmania donovani monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Theileria parva hypothetical protein Get druggable targets OG5_144587 All targets in OG5_144587
Trypanosoma congolense monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Theileria parva DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Theileria parva hypothetical protein Get druggable targets OG5_144587 All targets in OG5_144587
Neospora caninum hypothetical protein Get druggable targets OG5_127113 All targets in OG5_127113
Mycobacterium leprae Probable DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (Type II DNA topoisomerase) Get druggable targets OG5_128755 All targets in OG5_128755
Mycobacterium tuberculosis Possible lysophospholipase Get druggable targets OG5_127037 All targets in OG5_127037
Trypanosoma brucei trypanothione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Trypanosoma brucei monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Trypanosoma brucei DNA topoisomerase ii Get druggable targets OG5_128755 All targets in OG5_128755
Echinococcus multilocularis thioredoxin glutathione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein Get druggable targets OG5_127037 All targets in OG5_127037
Toxoplasma gondii ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein Get druggable targets OG5_128755 All targets in OG5_128755
Leishmania mexicana trypanothione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_127113 All targets in OG5_127113
Trypanosoma cruzi DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Trypanosoma cruzi monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Trypanosoma brucei DNA topoisomerase II beta, putative Get druggable targets OG5_127113 All targets in OG5_127113
Candida albicans similar to S. cerevisiae GLR1 (YPL091W) glutathione oxidoreductase Get druggable targets OG5_126785 All targets in OG5_126785
Schistosoma japonicum ko:K03164 DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium falciparum DNA topoisomerase 2 Get druggable targets OG5_127113 All targets in OG5_127113
Toxoplasma gondii hypothetical protein Get druggable targets OG5_144587 All targets in OG5_144587
Echinococcus granulosus DNA topoisomerase 2 alpha Get druggable targets OG5_127113 All targets in OG5_127113
Candida albicans similar to S. cerevisiae GLR1 (YPL091W) glutathione oxidoreductase Get druggable targets OG5_126785 All targets in OG5_126785
Onchocerca volvulus DNA topoisomerase 2 homolog Get druggable targets OG5_127113 All targets in OG5_127113
Neospora caninum hypothetical protein Get druggable targets OG5_128755 All targets in OG5_128755
Mycobacterium leprae POSSIBLE LYSOPHOSPHOLIPASE Get druggable targets OG5_127037 All targets in OG5_127037
Leishmania infantum monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Brugia malayi DNA gyrase/topoisomerase IV, A subunit family protein Get druggable targets OG5_127113 All targets in OG5_127113
Echinococcus granulosus thioredoxin glutathione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_127113 All targets in OG5_127113
Trypanosoma congolense DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium falciparum lysophospholipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Leishmania mexicana DNA topoisomerase ii Get druggable targets OG5_127113 All targets in OG5_127113
Babesia bovis DNA gyrase subunit B, putative Get druggable targets OG5_128755 All targets in OG5_128755
Loa Loa (eye worm) thioredoxin reductase Get druggable targets OG5_126785 All targets in OG5_126785
Trypanosoma brucei DNA topoisomerase II alpha, putative Get druggable targets OG5_127113 All targets in OG5_127113
Chlamydia trachomatis DNA gyrase subunit B Get druggable targets OG5_128755 All targets in OG5_128755
Plasmodium vivax PST-A protein Get druggable targets OG5_127037 All targets in OG5_127037
Trypanosoma brucei gambiense monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Trypanosoma congolense DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Mycobacterium ulcerans hypothetical protein Get druggable targets OG5_127037 All targets in OG5_127037
Leishmania mexicana monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Plasmodium berghei glutathione reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
Plasmodium knowlesi thioredoxin reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
Cryptosporidium hominis DNA topoisomerase II Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium vivax DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium berghei DNA gyrase subunit B, putative Get druggable targets OG5_128755 All targets in OG5_128755
Trypanosoma brucei gambiense DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Trypanosoma congolense monoglyceride lipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Plasmodium yoelii thioredoxin reductase Get druggable targets OG5_126785 All targets in OG5_126785
Trichomonas vaginalis conserved hypothetical protein Get druggable targets OG5_127037 All targets in OG5_127037
Plasmodium falciparum esterase, putative Get druggable targets OG5_144587 All targets in OG5_144587
Mycobacterium tuberculosis DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (type II DNA topoisomerase) Get druggable targets OG5_128755 All targets in OG5_128755
Theileria parva hypothetical protein Get druggable targets OG5_144587 All targets in OG5_144587
Leishmania donovani DNA topoisomerase ii Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium vivax glutathione reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
Plasmodium berghei thioredoxin reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
Trypanosoma brucei gambiense DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase Get druggable targets OG5_127037 All targets in OG5_127037
Leishmania infantum DNA topoisomerase ii Get druggable targets OG5_127113 All targets in OG5_127113
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_127113 All targets in OG5_127113
Loa Loa (eye worm) TOPoisomerase family member Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium yoelii DNA topoisomerase II, putative Get druggable targets OG5_128755 All targets in OG5_128755
Plasmodium falciparum lysophospholipase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Trypanosoma cruzi DNA topoisomerase II, putative Get druggable targets OG5_127113 All targets in OG5_127113
Mycobacterium ulcerans DNA gyrase subunit B Get druggable targets OG5_128755 All targets in OG5_128755
Leishmania major trypanothione reductase Get druggable targets OG5_126785 All targets in OG5_126785
Plasmodium vivax lysophospholipase, putative Get druggable targets OG5_144587 All targets in OG5_144587
Leishmania major DNA topoisomerase ii Get druggable targets OG5_127113 All targets in OG5_127113
Mycobacterium ulcerans lysophospholipase Get druggable targets OG5_127037 All targets in OG5_127037
Plasmodium falciparum lysophospholipase, putative Get druggable targets OG5_144587 All targets in OG5_144587
Plasmodium berghei DNA topoisomerase 2, putative Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium vivax thioredoxin reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
Plasmodium falciparum thioredoxin reductase Get druggable targets OG5_126785 All targets in OG5_126785
Brugia malayi Probable DNA topoisomerase II Get druggable targets OG5_127113 All targets in OG5_127113
Leishmania major mitochondrial DNA topoisomerase II Get druggable targets OG5_128755 All targets in OG5_128755
Candida albicans DNA topoisomerase II similar to S. cerevisiae TOP2 (YNL088W) Get druggable targets OG5_127113 All targets in OG5_127113
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_127113 All targets in OG5_127113
Leishmania braziliensis DNA topoisomerase ii Get druggable targets OG5_127113 All targets in OG5_127113
Trypanosoma cruzi mitochondrial DNA topoisomerase II, putative Get druggable targets OG5_128755 All targets in OG5_128755
Trichomonas vaginalis valacyclovir hydrolase, putative Get druggable targets OG5_127037 All targets in OG5_127037
Trypanosoma cruzi mitochondrial DNA topoisomerase II, putative Get druggable targets OG5_128755 All targets in OG5_128755
Brugia malayi DNA topoisomerase II, alpha isozyme Get druggable targets OG5_127113 All targets in OG5_127113
Plasmodium knowlesi glutathione reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
Trypanosoma brucei gambiense trypanothione reductase, putative Get druggable targets OG5_126785 All targets in OG5_126785
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Plasmodium falciparum dihydrolipoyl dehydrogenase, apicoplast trypanothione reductase 491 aa 551 aa 23.4 %
Plasmodium falciparum lysophospholipase, putative esterase, putative 373 aa 405 aa 51.6 %
Trypanosoma brucei DNA topoisomerase II beta, putative mitochondrial DNA topoisomerase II 1236 aa 1047 aa 35.1 %
Plasmodium falciparum lysophospholipase, putative lysophospholipase, putative 353 aa 379 aa 44.3 %
Plasmodium falciparum dihydrolipoyl dehydrogenase, apicoplast trypanothione reductase, putative 492 aa 548 aa 21.5 %
Plasmodium falciparum lysophospholipase, putative lysophospholipase, putative 371 aa 380 aa 41.0 %
Plasmodium falciparum dihydrolipoyl dehydrogenase, apicoplast trypanothione reductase, putative 189 aa 197 aa 20.8 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Toxoplasma gondii thioredoxin reductase 0.0192 1 1
Plasmodium vivax thioredoxin reductase, putative 0.0192 1 1
Onchocerca volvulus DNA topoisomerase 2 homolog 0.0114 0.4744 0.5
Wolbachia endosymbiont of Brugia malayi DNA gyrase, topoisomerase II, B subunit, GyrB 0.0098 0.3687 1
Onchocerca volvulus DNA topoisomerase 2 homolog 0.0114 0.4744 0.5
Plasmodium vivax DNA topoisomerase II, putative 0.0169 0.8443 0.7684
Loa Loa (eye worm) hypothetical protein 0.0114 0.4755 0.3699
Brugia malayi Probable DNA topoisomerase II 0.0169 0.8443 0.8141
Mycobacterium ulcerans lysophospholipase 0.0173 0.8756 1
Leishmania major mitochondrial DNA topoisomerase II 0.0189 0.9839 0.976
Plasmodium falciparum glutathione reductase 0.0192 1 1
Trypanosoma brucei monoglyceride lipase, putative 0.0173 0.8756 0.815
Plasmodium vivax lysophospholipase, putative 0.0178 0.9044 0.8578
Plasmodium falciparum esterase, putative 0.0173 0.8756 0.815
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0173 0.8756 0.9501
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0092 0.3276 0.7054
Leishmania major DNA topoisomerase ii 0.016 0.7827 0.6768
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0092 0.3276 0.3741
Trichomonas vaginalis DNA topoisomerase II, putative 0.0169 0.8443 0.8958
Echinococcus granulosus DNA topoisomerase 2 alpha 0.0169 0.8443 0.7684
Plasmodium falciparum lysophospholipase, putative 0.0178 0.9044 0.8578
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.0092 0.3276 0.1976
Trichomonas vaginalis conserved hypothetical protein 0.0178 0.9044 1
Plasmodium falciparum thioredoxin reductase 0.0192 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0173 0.8756 0.9501
Trypanosoma brucei monoglyceride lipase, putative 0.0173 0.8756 0.815
Trypanosoma cruzi mitochondrial DNA topoisomerase II, putative 0.0189 0.9839 0.976
Loa Loa (eye worm) glutathione reductase 0.0192 1 1
Plasmodium falciparum lysophospholipase, putative 0.0173 0.8756 0.815
Plasmodium vivax DNA gyrase subunit B, putative 0.0098 0.3687 0.0612
Trichomonas vaginalis valacyclovir hydrolase, putative 0.0173 0.8756 0.9501
Trypanosoma cruzi mitochondrial DNA topoisomerase II, putative 0.0189 0.9839 0.976
Trypanosoma brucei DNA topoisomerase ii 0.0189 0.9839 0.976
Giardia lamblia DNA topoisomerase II 0.016 0.7848 1
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0173 0.8756 0.9501
Brugia malayi DNA gyrase/topoisomerase IV, A subunit family protein 0.0169 0.8443 0.8141
Loa Loa (eye worm) TOPoisomerase family member 0.0169 0.8443 0.8129
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein 0.0173 0.8756 0.5217
Leishmania major trypanothione reductase 0.0192 1 1
Toxoplasma gondii ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein 0.0098 0.3687 0.0612
Brugia malayi Thioredoxin reductase 0.0192 1 1
Schistosoma mansoni DNA topoisomerase II 0.0169 0.8443 0.7684
Echinococcus granulosus thioredoxin glutathione reductase 0.0192 1 1
Echinococcus multilocularis thioredoxin glutathione reductase 0.0192 1 1
Mycobacterium leprae POSSIBLE LYSOPHOSPHOLIPASE 0.0173 0.8756 1
Plasmodium falciparum DNA gyrase subunit B 0.0098 0.3687 0.0612
Loa Loa (eye worm) thioredoxin reductase 0.0192 1 1
Plasmodium falciparum esterase, putative 0.0178 0.9044 0.8578
Plasmodium vivax unspecified product 0.0178 0.9044 0.8578
Plasmodium falciparum DNA topoisomerase 2 0.0169 0.8443 0.7684
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein 0.0178 0.9044 1
Plasmodium falciparum lysophospholipase, putative 0.0173 0.8756 0.815
Brugia malayi DNA topoisomerase II, alpha isozyme 0.0169 0.8443 0.8141
Plasmodium falciparum esterase, putative 0.0178 0.9044 0.8578
Toxoplasma gondii DNA topoisomerase 2, putative 0.0169 0.8443 0.7684
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0192 1 1
Plasmodium falciparum lysophospholipase, putative 0.0173 0.8756 0.815
Chlamydia trachomatis DNA gyrase subunit B 0.0098 0.3687 1
Mycobacterium ulcerans hypothetical protein 0.0173 0.8756 1
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0173 0.8756 0.9501
Trypanosoma cruzi DNA topoisomerase II, putative 0.016 0.7827 0.6768
Toxoplasma gondii hypothetical protein 0.0178 0.9044 0.8578
Mycobacterium tuberculosis DNA gyrase (subunit B) GyrB (DNA topoisomerase (ATP-hydrolysing)) (DNA topoisomerase II) (type II DNA topoisomerase) 0.0098 0.3687 0.0612
Mycobacterium tuberculosis Possible lysophospholipase 0.0173 0.8756 0.815
Plasmodium vivax PST-A protein 0.0173 0.8756 0.815
Treponema pallidum DNA gyrase, subunit B (gyrB) 0.0098 0.3687 1
Trypanosoma brucei DNA topoisomerase II beta, putative 0.016 0.7827 0.6768
Trypanosoma brucei DNA topoisomerase II alpha, putative 0.016 0.7827 0.6768
Echinococcus multilocularis DNA topoisomerase 2 alpha 0.0169 0.8443 0.7684
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0173 0.8756 0.9501
Trypanosoma cruzi trypanothione reductase, putative 0.0192 1 1
Trichomonas vaginalis Clan SC, family S33, methylesterase-like serine peptidase 0.0173 0.8756 0.9501
Plasmodium vivax glutathione reductase, putative 0.0192 1 1
Trypanosoma cruzi monoglyceride lipase, putative 0.0173 0.8756 0.815
Trypanosoma brucei trypanothione reductase 0.0192 1 1
Trypanosoma cruzi DNA topoisomerase II, putative 0.016 0.7827 0.6768
Entamoeba histolytica hydrolase, alpha/beta fold family domain containing protein 0.0173 0.8756 0.5217
Trichomonas vaginalis conserved hypothetical protein 0.0173 0.8756 0.9501
Leishmania major monoglyceride lipase, putative 0.0173 0.8756 0.815
Onchocerca volvulus Putative DNA topoisomerase 2, mitochondrial 0.0114 0.4744 0.5
Loa Loa (eye worm) hypothetical protein 0.0114 0.4755 0.3699
Mycobacterium ulcerans DNA gyrase subunit B 0.0098 0.3687 0.0751

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

Affected Entity Phenotypic quality Occurs in Occurs at Evidence Observed in Targets
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) amastigote (BTO:0000062) inferred from bioassay (ECO:0000094) Leishmania donovani 22664  
Annotator: aaronjr@u.washington.edu Comment: chemical inhibition with various inhibitors leads to slow growth of Leishmania sp. in cell assay; quinacrine analogues References: 11551771
cytolysis (GO:0019835) increased (PATO:0000470) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania chagasi 22297  
Annotator: aaronjr@u.washington.edu Comment: Drug: 13365-36-1; Drug: 61421-82-7; Drug: 61421-83-8; Drug: 139501-99-8. chemical inhibition with topoisomerase inhibitors leads to lysis and reduced motility; unclear as to which topoisomerase II gene/enzyme was studied References: 1318684
cytolysis (GO:0019835) increased (PATO:0000470) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania chagasi 22658  
Annotator: aaronjr@u.washington.edu Comment: Drug: 13365-36-1; Drug: 61421-82-7; Drug: 61421-83-8; Drug: 139501-99-8. chemical inhibition with topoisomerase inhibitors leads to lysis and reduced motility; unclear as to which topoisomerase II gene/enzyme was studied References: 1318684
cytolysis (GO:0019835) increased (PATO:0000470) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 22297  
Annotator: aaronjr@u.washington.edu Comment: Drug: 13365-36-1; Drug: 61421-82-7; Drug: 61421-83-8; Drug: 139501-99-8. chemical inhibition with topoisomerase inhibitors leads to lysis and reduced motility; unclear as to which topoisomerase II gene/enzyme was studied References: 1318684
cytolysis (GO:0019835) increased (PATO:0000470) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 22658  
Annotator: aaronjr@u.washington.edu Comment: Drug: 13365-36-1; Drug: 61421-82-7; Drug: 61421-83-8; Drug: 139501-99-8. chemical inhibition with topoisomerase inhibitors leads to lysis and reduced motility; unclear as to which topoisomerase II gene/enzyme was studied References: 1318684
cell motility (GO:0006928) decreased (PATO:0000468) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania chagasi 22297  
Annotator: aaronjr@u.washington.edu Comment: Drug: 13365-36-1; Drug: 61421-82-7; Drug: 61421-83-8; Drug: 139501-99-8. chemical inhibition with topoisomerase inhibitors leads to lysis and reduced motility; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 1318684
cell motility (GO:0006928) decreased (PATO:0000468) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania chagasi 22658  
Annotator: aaronjr@u.washington.edu Comment: Drug: 13365-36-1; Drug: 61421-82-7; Drug: 61421-83-8; Drug: 139501-99-8. chemical inhibition with topoisomerase inhibitors leads to lysis and reduced motility; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 1318684
cell motility (GO:0006928) decreased (PATO:0000468) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 22297  
Annotator: aaronjr@u.washington.edu Comment: Drug: 13365-36-1; Drug: 61421-82-7; Drug: 61421-83-8; Drug: 139501-99-8. chemical inhibition with topoisomerase inhibitors leads to lysis and reduced motility; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 1318684
cell motility (GO:0006928) decreased (PATO:0000468) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania donovani 22658  
Annotator: aaronjr@u.washington.edu Comment: Drug: 13365-36-1; Drug: 61421-82-7; Drug: 61421-83-8; Drug: 139501-99-8. chemical inhibition with topoisomerase inhibitors leads to lysis and reduced motility; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 1318684
chromosomal_structural_element (SO:0000628) biosynthetic process (GO:0009058) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania chagasi 22297  
Annotator: crowther@u.washington.edu Comment: Drug: 13365-36-1; Drug: 13365-38-3; Drug: 61421-82-7; Drug: 61462-75-7; Drug: 62382-99-4; Drug: 75775-90-5; Drug: 136633-55-1. chemical inhibition with topoisomerase inhibitors leads to generation of cleavable complex and growth inhibition; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 7935616
chromosomal_structural_element (SO:0000628) biosynthetic process (GO:0009058) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania chagasi 22658  
Annotator: crowther@u.washington.edu Comment: Drug: 13365-36-1; Drug: 13365-38-3; Drug: 61421-82-7; Drug: 61462-75-7; Drug: 62382-99-4; Drug: 75775-90-5; Drug: 136633-55-1. chemical inhibition with topoisomerase inhibitors leads to generation of cleavable complex and growth inhibition; unclear as to which topoisomerase I gene(s)/enzyme(s) was/were studied References: 7935616
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania chagasi 22297  
Annotator: crowther@u.washington.edu Comment: Drug: 13365-36-1; Drug: 13365-38-3; Drug: 61421-82-7; Drug: 61462-75-7; Drug: 62382-99-4; Drug: 75775-90-5; Drug: 136633-55-1. chemical inhibition with topoisomerase inhibitors leads to generation of cleavable complex and growth inhibition; unclear as to which topoisomerase II gene/enzyme was studied References: 7935616
growth (GO:0040007) decreased time (PATO:0000716) single cell organism (CARO:0000064) promastigote (BTO:0001124) inferred from bioassay (ECO:0000094) Leishmania chagasi 22658  
Annotator: crowther@u.washington.edu Comment: Drug: 13365-36-1; Drug: 13365-38-3; Drug: 61421-82-7; Drug: 61462-75-7; Drug: 62382-99-4; Drug: 75775-90-5; Drug: 136633-55-1. chemical inhibition with topoisomerase inhibitors leads to generation of cleavable complex and growth inhibition; unclear as to which topoisomerase II gene/enzyme was studied References: 7935616
growth (GO:0040007) lethal (sensu genetics) (PATO:0000718) multi-cellular organism (CARO:0000012) bloodstream stage (PLO:0040) in vivo inhibition (TDR:00016) Plasmodium falciparum 2350  
Annotator: saralph@unimelb.edu.au Comment: 012/Mar/09 References: 8022653
growth (GO:0040007) lethal (sensu genetics) (PATO:0000718) multi-cellular organism (CARO:0000012) bloodstream stage (PLO:0040) in vivo inhibition (TDR:00016) Plasmodium falciparum 3067  
Annotator: saralph@unimelb.edu.au Comment: 012/Mar/09 References: 8022653
growth (GO:0040007) lethal (sensu genetics) (PATO:0000718) multi-cellular organism (CARO:0000012) bloodstream stage (PLO:0040) in vivo inhibition (TDR:00016) Plasmodium falciparum 3068  
Annotator: saralph@unimelb.edu.au Comment: 012/Mar/09 References: 8022653
catalytic activity (GO:0003824) decreased (PATO:0000468) inferred from enzyme inhibition (ECO:0000184) Trypanosoma cruzi 35349  
Annotator: millerja@u.washington.edu Comment: References: 11328673 17439174 19296695 19747949
catalytic activity (GO:0003824) decreased (PATO:0000468) inferred from enzyme inhibition (ECO:0000184) Trypanosoma cruzi 50541  
Annotator: millerja@u.washington.edu Comment: References: 11328673 17439174 19296695 19747949

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

150 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.